Navigation Links
Reliv International's Carl W. Hastings Elected to Board of the Council for Responsible Nutrition

CHESTERFIELD, Mo., Dec. 21 /PRNewswire-FirstCall/ -- Dr. Carl W. Hastings, vice chairman and chief scientific officer of Reliv International, Inc., was elected to the board of directors of the Council for Responsible Nutrition (CRN), the nation's leading trade association for the dietary supplement industry.

Dr. Hastings oversees research, development of nutritional products, quality control and manufacturing for Reliv, a direct selling company of nutritional products. He has created Reliv's core product line and is the holder of five patents for his work, and patents are pending on additional products.

"I share the values of the Council for Responsible Nutrition, particularly its dedication to advancing scientific research of dietary supplements and its commitment to a strong code of ethics," Dr. Hastings said.

Dr. Hastings, 67, joined Reliv as head of research and development shortly after the company was founded. He holds U.S. patents for Innergize!®, FibRestore®, Cellebrate®, Arthaffect® and ReversAge®, and has patents pending on CardioSentials and GlucAffect.

His career spans nearly 40 years in food product research and development, beginning at Mead Johnson & Co. where Dr. Hastings conducted research on nutritional food products for adults and infants, and developed low-calorie foods marketed under the Weight Watchers label.

With the A.E. Staley Company, Dr. Hastings developed new applications for food ingredients from corn and soybeans, including starch, sweeteners, protein and fiber.

Dr. Hastings earned a Ph.D. in food science from the University of Illinois, where he also earned his bachelor's and master's degrees.

Reliv International, Inc., based in Chesterfield, Mo., is a developer, manufacturer and marketer of a proprietary line of nutritional supplements. Reliv supplements address essential daily nutrition, weight loss and targeted solutions such as energy and performance enhancement, digestive health, women's health and anti-aging. Reliv sells its products through an international network marketing system of approximately 68,000 independent distributors. Additional information about Reliv International, Inc. can be obtained on the Web at

SOURCE Reliv International, Inc.

SOURCE Reliv International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reliv International Hires Director of Strategic Development
2. Reliv Walk for the Mission Raises Approximately $47,000 for Malnourished People
3. Reliv International Launches New Products and Business Tools at 21st International Conference
4. Reliv International Launches Relivables(TM) Product Family With New Skincare Products and Other Items
5. Reliv Foundation Builds Feeding Center and School for Impoverished People in Haiti
6. Reliv International Named As Finalist In the American Business Awards
7., First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals
8. CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today
9. Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference
10. Dr. Larry Kaskel, Medical Director of the Heart Attack Prevention Center, to Speak March 4th at CardioCareLive about FirstLine Therapy
11. Minnesota Nurses Support SEIU Workers at Regina Medical Center, Hastings
Post Your Comments:
(Date:12/1/2015)... PITTSBURGH, PA (PRWEB) , ... December 01, 2015 ... ... or imaging facilities, radiographic technicians must mark the film for accurate interpretation by ... keep track of. Fortunately, an inventor from Sacramento, Calif., has found a way ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... it has been selected as a finalist in this year’s Fierce Innovation Awards: ... Next IT Healthcare was recognized as a finalist in the category of Digital ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s latest white paper, ... addresses a main “pain point” for merging or aligning healthcare provider organizations—when mergers ... is signed. This quick-read guidance suggests that failing to recognize the power ...
(Date:12/1/2015)... ... 01, 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, ... , The order will be from the China Disabled Persons’ Federation, a central government ... effective solution for children and adults suffering from severe and profound hearing loss ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... companies, announced today that it has officially launched a sleek, mobile-ready and user-centric ... that his company’s new website clearly outlines the benefits that its SEO services ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Calif. , Dec. 1, 2015  Avanir ... prevalence of symptoms for pseudobulbar affect (PBA), a ... of laughing and/or crying resulting from certain neurologic ... of antipsychotic medications in nursing home residents, were ... Psychiatry. The study showed that almost one in ...
(Date:12/1/2015)... December 1, 2015 Biovicas ... Study Group (IBCSG, Bern ) ... i en klinisk studie av palbociclib, ett nytt ... --> Studien, med namn PYTHIA, kommer följa ... läkemedel i kombination med palbociclib, som tillhör klassen ...
(Date:11/30/2015)... 1, 2015 Express Scripts (NASDAQ: ESRX ) ... IMMY ) to drive access to a low-cost alternative to ... toxoplasmosis that has been recently priced out of reach for ... systems. --> --> Imprimis ... (a form of folic acid) for $1 per capsule for people ...
Breaking Medicine Technology: